1.
Bioorg Med Chem Lett
; 9(9): 1261-6, 1999 May 03.
Artículo
en Inglés
| MEDLINE
| ID: mdl-10340611
RESUMEN
The synthesis and biological activities of a series of spiroheterocyclic growth hormone secretagogues are reported. Modification of the spiroindane part-structure of the prototypal secretagogue L-162,752 revealed that the spiroindane could be replaced with spirobenzodihydrothiophen derivatives to enhance not only in vitro potency but also oral activity. In this study non-aromatic D-2-amino-4-cyclohexylbutanoic analogs (8a-8d) were also identified to be active secretagogues.